AGRANA BETEILIGUNGS AG (AGB2.DE) Stock Fundamental Analysis

FRA:AGB2 • AT000AGRANA3

12.25 EUR
+0.1 (+0.82%)
Last: Sep 11, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall AGB2 gets a fundamental rating of 4 out of 10. We evaluated AGB2 against 63 industry peers in the Food Products industry. While AGB2 seems to be doing ok healthwise, there are quite some concerns on its profitability. AGB2 is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year AGB2 has reported negative net income.
  • AGB2 had a positive operating cash flow in the past year.
  • In multiple years AGB2 reported negative net income over the last 5 years.
  • AGB2 had a positive operating cash flow in 4 of the past 5 years.
AGB2.DE Yearly Net Income VS EBIT VS OCF VS FCFAGB2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • With a Return On Assets value of -0.16%, AGB2 is not doing good in the industry: 74.14% of the companies in the same industry are doing better.
  • AGB2's Return On Equity of -0.37% is on the low side compared to the rest of the industry. AGB2 is outperformed by 74.14% of its industry peers.
  • With a Return On Invested Capital value of 2.26%, AGB2 is not doing good in the industry: 72.41% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for AGB2 is below the industry average of 7.30%.
Industry RankSector Rank
ROA -0.16%
ROE -0.37%
ROIC 2.26%
ROA(3y)0.87%
ROA(5y)0.91%
ROE(3y)2.14%
ROE(5y)2.02%
ROIC(3y)4.95%
ROIC(5y)4.06%
AGB2.DE Yearly ROA, ROE, ROICAGB2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8 10

1.3 Margins

  • With a Operating Margin value of 1.68%, AGB2 is not doing good in the industry: 75.86% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of AGB2 has declined.
  • Looking at the Gross Margin, with a value of 27.30%, AGB2 is doing worse than 77.59% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AGB2 has declined.
Industry RankSector Rank
OM 1.68%
PM (TTM) N/A
GM 27.3%
OM growth 3Y-14.93%
OM growth 5Y-10.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5Y-2.99%
AGB2.DE Yearly Profit, Operating, Gross MarginsAGB2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AGB2 is creating some value.
  • Compared to 1 year ago, AGB2 has about the same amount of shares outstanding.
  • Compared to 5 years ago, AGB2 has about the same amount of shares outstanding.
  • AGB2 has a better debt/assets ratio than last year.
AGB2.DE Yearly Shares OutstandingAGB2.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AGB2.DE Yearly Total Debt VS Total AssetsAGB2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.35 indicates that AGB2 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.35, AGB2 is in line with its industry, outperforming 53.45% of the companies in the same industry.
  • The Debt to FCF ratio of AGB2 is 2.25, which is a good value as it means it would take AGB2, 2.25 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of AGB2 (2.25) is better than 87.93% of its industry peers.
  • A Debt/Equity ratio of 0.45 indicates that AGB2 is not too dependend on debt financing.
  • AGB2 has a Debt to Equity ratio of 0.45. This is in the better half of the industry: AGB2 outperforms 60.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.25
Altman-Z 2.35
ROIC/WACC0.54
WACC4.15%
AGB2.DE Yearly LT Debt VS Equity VS FCFAGB2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • AGB2 has a Current Ratio of 2.02. This indicates that AGB2 is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of AGB2 (2.02) is better than 74.14% of its industry peers.
  • AGB2 has a Quick Ratio of 2.02. This is a bad value and indicates that AGB2 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AGB2 has a Quick ratio of 0.98. This is comparable to the rest of the industry: AGB2 outperforms 56.90% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 0.98
AGB2.DE Yearly Current Assets VS Current LiabilitesAGB2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • AGB2 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -106.55%.
  • AGB2 shows a decrease in Revenue. In the last year, the revenue decreased by -7.21%.
  • Measured over the past years, AGB2 shows a small growth in Revenue. The Revenue has been growing by 7.21% on average per year.
EPS 1Y (TTM)-106.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.36%
Revenue 1Y (TTM)-7.21%
Revenue growth 3Y6.59%
Revenue growth 5Y7.21%
Sales Q2Q%-7.66%

3.2 Future

  • AGB2 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 206.29% yearly.
  • The Revenue is expected to grow by 0.27% on average over the next years.
EPS Next Y753.91%
EPS Next 2Y371.51%
EPS Next 3Y206.29%
EPS Next 5YN/A
Revenue Next Year-2.75%
Revenue Next 2Y-0.58%
Revenue Next 3Y0.27%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AGB2.DE Yearly Revenue VS EstimatesAGB2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
AGB2.DE Yearly EPS VS EstimatesAGB2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • AGB2 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 32.78 indicates a quite expensive valuation of AGB2.
  • Based on the Price/Forward Earnings ratio, AGB2 is valued a bit more expensive than 67.24% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. AGB2 is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 32.78
AGB2.DE Price Earnings VS Forward Price EarningsAGB2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AGB2 is valued a bit cheaper than 65.52% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AGB2 is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.3
EV/EBITDA 7.31
AGB2.DE Per share dataAGB2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AGB2's earnings are expected to grow with 206.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y371.51%
EPS Next 3Y206.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • AGB2 has a Yearly Dividend Yield of 6.47%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.42, AGB2 pays a better dividend. On top of this AGB2 pays more dividend than 94.83% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, AGB2 pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.47%

5.2 History

  • The dividend of AGB2 decreases each year by -2.02%.
Dividend Growth(5Y)-2.02%
Div Incr Years0
Div Non Decr Years2
AGB2.DE Yearly Dividends per shareAGB2.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

DPN/A
EPS Next 2Y371.51%
EPS Next 3Y206.29%
AGB2.DE Yearly Income VS Free CF VS DividendAGB2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

More info and screens

Find the best dividend stocksShow peers with best dividend

AGRANA BETEILIGUNGS AG

FRA:AGB2 (9/11/2025, 7:00:00 PM)

12.25

+0.1 (+0.82%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-10
Earnings (Next)10-09
Inst Owners3.89%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap765.50M
Revenue(TTM)3.51B
Net Income(TTM)-4.25M
Analysts48.89
Price Target12.51 (2.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.47%
Yearly Dividend0.9
Dividend Growth(5Y)-2.02%
DPN/A
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.41%
PT rev (3m)5.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-51.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 32.78
P/S 0.22
P/FCF 2.3
P/OCF 2.3
P/B 0.66
P/tB 0.73
EV/EBITDA 7.31
EPS(TTM)-0.07
EYN/A
EPS(NY)0.37
Fwd EY3.05%
FCF(TTM)5.33
FCFY43.51%
OCF(TTM)5.33
OCFY43.51%
SpS56.23
BVpS18.53
TBVpS16.72
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.16%
ROE -0.37%
ROCE 3.21%
ROIC 2.26%
ROICexc 2.4%
ROICexgc 2.57%
OM 1.68%
PM (TTM) N/A
GM 27.3%
FCFM 9.48%
ROA(3y)0.87%
ROA(5y)0.91%
ROE(3y)2.14%
ROE(5y)2.02%
ROIC(3y)4.95%
ROIC(5y)4.06%
ROICexc(3y)5.29%
ROICexc(5y)4.34%
ROICexgc(3y)5.67%
ROICexgc(5y)4.74%
ROCE(3y)7.03%
ROCE(5y)5.77%
ROICexgc growth 3Y-8.01%
ROICexgc growth 5Y-1.02%
ROICexc growth 3Y-6.34%
ROICexc growth 5Y0.4%
OM growth 3Y-14.93%
OM growth 5Y-10.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5Y-2.99%
F-Score4
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.25
Debt/EBITDA 2.7
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 173.14%
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 0.98
Altman-Z 2.35
F-Score4
WACC4.15%
ROIC/WACC0.54
Cap/Depr(3y)67.85%
Cap/Depr(5y)61.1%
Cap/Sales(3y)2.8%
Cap/Sales(5y)2.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-106.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.36%
EPS Next Y753.91%
EPS Next 2Y371.51%
EPS Next 3Y206.29%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.21%
Revenue growth 3Y6.59%
Revenue growth 5Y7.21%
Sales Q2Q%-7.66%
Revenue Next Year-2.75%
Revenue Next 2Y-0.58%
Revenue Next 3Y0.27%
Revenue Next 5YN/A
EBIT growth 1Y-65.39%
EBIT growth 3Y-9.32%
EBIT growth 5Y-3.58%
EBIT Next Year255.85%
EBIT Next 3Y67.97%
EBIT Next 5YN/A
FCF growth 1Y567.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y567.78%
OCF growth 3Y96.06%
OCF growth 5Y26.82%

AGRANA BETEILIGUNGS AG / AGB2.DE FAQ

What is the fundamental rating for AGB2 stock?

ChartMill assigns a fundamental rating of 4 / 10 to AGB2.DE.


Can you provide the valuation status for AGRANA BETEILIGUNGS AG?

ChartMill assigns a valuation rating of 4 / 10 to AGRANA BETEILIGUNGS AG (AGB2.DE). This can be considered as Fairly Valued.


What is the profitability of AGB2 stock?

AGRANA BETEILIGUNGS AG (AGB2.DE) has a profitability rating of 1 / 10.


What is the earnings growth outlook for AGRANA BETEILIGUNGS AG?

The Earnings per Share (EPS) of AGRANA BETEILIGUNGS AG (AGB2.DE) is expected to grow by 753.91% in the next year.